Newron Pharmaceuticals S.p.A.

PRESS RELEASE

published on 04/08/2024 at 07:00, 2 years 4 months ago

Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)
Newron Pharmaceuticals presented data from study 014/015 and evenamide clinical development outlook at SIRS 2024 Congress, showcasing potential for new TRS treatment options

Clinical Development Newron Pharmaceuticals Evenamide Study 014/015 Schizophrenia International Research Society
BRIEF

published on 03/19/2024 at 07:05, 2 years 5 months ago

Newron Pharmaceuticals S.p.A. Announces 2023 Financial Results and Provides Outlook for 2024

2024 Outlook Financial Results 2023 Newron Pharmaceuticals Evenamide Development Xadago Safinamide
BRIEF

published on 03/19/2024 at 07:05, 2 years 5 months ago

Newron Pharmaceuticals SpA annonce ses résultats financiers pour 2023 et fournit des perspectives pour 2024

Perspectives 2024 Résultats Financiers 2023 Produits Pharmaceutiques Newron Xadago Safinamide Développement D'Evenamide
PRESS RELEASE

published on 03/19/2024 at 07:00, 2 years 5 months ago

Newron presents 2023 financial results and provides 2024 outlook
Newron Pharmaceuticals S.p.A. presents 2023 financial results and 2024 outlook, including advancements in schizophrenia treatment and strategic partnerships

Financial Results 2024 Outlook Partnerships Newron Pharmaceuticals Schizophrenia Treatment
BRIEF

published on 03/15/2024 at 07:05, 2 years 5 months ago

Newron Pharmaceuticals S.p.A. Announces Amended Repayment Agreement with European Investment Bank

European Investment Bank Newron Pharmaceuticals Financing Agreement Evenamide CNS Treatments
BRIEF

published on 03/15/2024 at 07:05, 2 years 5 months ago

Newron Pharmaceuticals SpA annonce un accord de remboursement modifié avec la Banque européenne d'investissement

Produits Pharmaceutiques Newron Evenamide Banque Européenne D'investissement Accord De Financement Traitements Du SNC
PRESS RELEASE

published on 03/15/2024 at 07:00, 2 years 5 months ago

Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement
Newron Pharmaceuticals S.p.A. agrees with EIB to extend repayment dates of 2018 financing agreement tranches after pipeline milestones

European Investment Bank Financing Agreement Evenamide Newron Pharmaceuticals S.p.A. Loan Repayment Dates
BRIEF

published on 03/14/2024 at 18:37, 2 years 5 months ago

Newron Pharmaceuticals Secures Up to EUR 15 Million in Funding Through New Share Issuance

Share Issuance Biopharmaceuticals Investment Agreement Newron Pharmaceuticals CNS Therapies
BRIEF

published on 03/14/2024 at 18:37, 2 years 5 months ago

Newron Pharmaceuticals obtient jusqu'à 15 millions d'euros de financement grâce à l'émission de nouvelles actions

Émission D'actions Produits Biopharmaceutiques Accord D'investissement Produits Pharmaceutiques Newron Thérapies Du SNC
PRESS RELEASE

published on 03/14/2024 at 18:32, 2 years 5 months ago

Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds of up to EUR 15.0 million
Newron Pharmaceuticals S.p.A. enters a subscription agreement for up to 2.05 million new shares, aiming to raise EUR 15.0 million. The investment supports CNS therapies development

Subscription Agreement Newron Pharmaceuticals Newly Issued Shares EUR 15.0 Million CNS Therapies Development

Published on 08/31/2026 at 23:00, 20 minutes ago

Silver Storm Closes Second and Final Tranche of Non-Brokered Private Placement for Aggregate Gross Proceeds of $21.0 Million
Published on 08/31/2026 at 22:55, 25 minutes ago

Alset AI Ventures Reports Fiscal Q3 2026 Results, Including $4.1 Million Unrealized, Non-Cash Investment Gain
Published on 08/31/2026 at 22:15, 1 hour 5 minutes ago

Namibia Critical Metals Provides Update on Lofdal Joint Venture Transaction
Published on 08/31/2026 at 22:00, 1 hour 20 minutes ago

NV Gold Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 08/31/2026 at 17:22, 5 hours 58 minutes ago

ACCESS Newswire Expands the Marketplace with Two New Partners: TVEyes and Listicle Liaison

View all ACCESSWIRE

Published on 08/31/2026 at 22:07, 1 hour 12 minutes ago

VIB Vermögen AG with successful Annual General Meeting and effective control and profit transfer agreement
Published on 08/31/2026 at 19:31, 3 hours 49 minutes ago

DEAG reports strong results for the first half of 2026
Published on 08/31/2026 at 19:15, 4 hours 4 minutes ago

CGTN: How China-Kyrgyzstan 'golden' ties deliver for both nations and the region
Published on 08/31/2026 at 19:00, 4 hours 20 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 24 AOUT 2026 au 28 AOUT 2026
Published on 08/31/2026 at 18:20, 5 hours ago

CPI PROPERTY GROUP publishes financial results for the first half of 2026

View all EQS

Published on 08/31/2026 at 18:00, 5 hours 20 minutes ago

MISE A DISPOSITION RAPPORT FINANCIER ANNUEL 2025/2026
Published on 08/31/2026 at 17:45, 5 hours 35 minutes ago

Disclosure of transactions in own shares from August 24 to August 28, 2026
Published on 08/31/2026 at 17:45, 5 hours 35 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 24 au 28 août 2026
Published on 08/31/2026 at 17:45, 5 hours 35 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/31/2026 at 17:45, 5 hours 35 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News